RSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the need for awareness and prevention efforts.
Merck to boost Gardasil production; Increased demand for Sanofi’s RSV drug; Takeda addresses facility ‘impairment’
Endpoints News looked into earnings call transcripts to find information nuggets on biopharma manufacturing plans. We discovered that Merck and Sanofi are both aiming to
October 31, 2023